Physician profile
Connie D Sutter
NPI 1164487534
$2,861.94
in general payments reported to CMS, 2019-2025
19 companies · $369 in 2025
The $369 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $530 · 2020: $116 · 2021: $642 · 2022: $377 · 2023: $502 · 2024: $327 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,197.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Journey Medical Corporation | $673.51 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $444.62 | 2023-2025 | Sotyktu |
| Galderma Laboratories, L.P. | $424.64 | 2019-2021 | |
| Incyte Corporation | $170.22 | 2021-2023 | Opzelura |
| Celgene Corporation | $164.99 | 2019 | |
| Amgen INC. | $154.62 | 2020-2024 | Otezla |
| Genzyme Corporation | $141.50 | 2020-2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $136.10 | 2020-2021 | |
| Organon LLC | $124.55 | 2025 | Vtama |
| Dermavant Sciences, INC. | $98.74 | 2022 | |
| Pfizer INC. | $93.71 | 2019-2025 | |
| Leo Pharma INC. | $67.20 | 2019-2025 | Anzupgo |
| Regeneron Healthcare Solutions, INC. | $45.36 | 2022-2025 | Dupixent |
| Almirall LLC | $35.63 | 2021-2022 | |
| Lilly USA, LLC | $24.21 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $17.14 | 2022 | |
| Arcutis Biotherapeutics, INC. | $16.93 | 2024 | Zoryve |
| Genentech USA, INC. | $14.96 | 2021 | |
| Verrica Pharmaceuticals INC. | $13.31 | 2023 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Connie Sutter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.